As 2026 approaches, the clinical research and development landscape is evolving beyond traditional scientific innovation with ...
The pharmaceutical and medical device industries stand at an inflection point. After decades of reliance on traditional ...
Eli Lilly and Co. and Indiana University on Wednesday announced a new agreement that would see the Indianapolis-based ...
New sample types strengthen support for autoimmune, dermatology, rheumatology, and inflammation research SAN DIEGO, Dec. 3, 2025 /PRNewswire/ -- Sanguine Biosciences, a leading provider of ...
Morning Overview on MSN
GLP-1 drugs fail to slow Alzheimer’s in 2 major trials
Two of the most closely watched Alzheimer clinical trials of the decade have delivered a sobering verdict: GLP-1 drugs that ...
Clinical trial names span a broad range, from straightforward acronyms to more inspiring titles—see: Eli Lilly’s optimistically dubbed family of Triumph trials—to the downright ostentatious, like ...
Digit health technologies (DHT) are a key aspect of U.S. Health & Human Services (HHS) Secretary Robert F. Kennedy Jr.’s Make America Healthy ...
Increasing the diversity of clinical trial participants is all the rage these days. The numbers tell the story: According to Food and Drug Administration data, in 2020 75% of trial participants were ...
Correspondence to Dr Thomas Bandholm, Dept of Clinical Research, Copenhagen University Hospital, Amager and Hvidovre, Hvidovre DK-2650, Denmark; thomas.quaade.bandholm{at}regionh.dk The REPORT guide ...
Funding for clinical trials comes from a wide variety of sources, including government, private investors, charities, universities, and other research institutions, though the vast majority generally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback